Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
PLAINSBORO, N.J., Aug 31, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is featuring the MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System at the XIV World Congress of Neurological Surgery in Boston, Massachusetts, August 30
View HTML
Toggle Summary Integra NeuroSciences Features AccuDrain External CSF Drainage System at the Congress of Neurological Surgeons Annual Meeting
Integra NeuroSciences Features AccuDrain External CSF Drainage System at the Congress of Neurological Surgeons Annual Meeting PLAINSBORO, N.J., Oct. 12, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it is featuring the AccuDrain™ External CSF Drainage
View HTML
Toggle Summary Integra NeuroSciences Donates Camino® Monitoring Systems and LICOX® Brain Tissue Oxygen Monitoring System to US Army Hospital in Iraq
Integra NeuroSciences Donates Camino® Monitoring Systems and LICOX® Brain Tissue Oxygen Monitoring System to US Army Hospital in Iraq Plainsboro, New Jersey, October 13, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today responded to a request from the 207th Neurosurgery Team at
View HTML
Toggle Summary Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form
Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form Plainsboro, New Jersey, September 24, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing the Helitene®
View HTML
Toggle Summary Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent
Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent PLAINSBORO, N.J., Jan 14, 2002 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing Helitene® Absorbable
View HTML
Toggle Summary Integra NeuroSciences Awarded Neurosurgery Agreement By Premier, Inc.
Integra NeuroSciences Awarded Neurosurgery Agreement By Premier, Inc. Neurosurgical Products Offered at Substantial Savings Plainsboro, NJ / January 2, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported that it has been selected as a national supplier for Premier's
View HTML
Toggle Summary Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting
Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting PLAINSBORO, N.J., Oct 1, 2001 (BUSINESS WIRE) -- Integra NeuroSciences, the neurosurgical device division of Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced that it is
View HTML
Toggle Summary Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets
Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has launched the Camino® Single
View HTML
Toggle Summary Integra NeuroSciences Announces FDA Clearance to Market the Selector® Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures
Integra NeuroSciences Announces FDA Clearance to Market the Selector® Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has
View HTML
Toggle Summary Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter
Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter PLAINSBORO, N.J., April 9, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that
View HTML